An interventional study of Pain Management Team + Whole Health Coach (PMT-WHC) and Pain Management Team-Usual Care (PMT-UC) in Chronic Pain, sponsored by VA Office of Research and Development. Recruiting at 5 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-17.
Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 57 studies in Chronic Pain by VA Office of Research and Development — 14 open to participants now, 15 under way, none of them phase 3. Chronic Pain · VA Office of Research and Development.
Among the 57 studies in Chronic Pain by VA Office of Research and Development, this one is the 2nd largest by planned enrollment of the 53 interventional ones that give a count, is one of 4 that started in 2025, is one of 44 with no phase, reaches primary completion later than 12 of the 14 other live ones, and was the 54th registered.
3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.
Browse Chronic Pain studies →14 of the 57 studies in Chronic Pain by VA Office of Research and Development are open now, in 1 country. Recruiting first, the newest first:
VA Office of Research and Development · Sites in United States
Ages 18+
VA Office of Research and Development · Sites in United States
Ages 18–99 · Healthy volunteers
VA Office of Research and Development · Sites in United States
Ages 18+
VA Office of Research and Development · Sites in United States
Ages 18–89
VA Office of Research and Development · Sites in United States
Ages 18+
By country, each count listing its studies:
Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
57 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 4 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 432 is above the median of 60 across 2,388 interventional studies indexed under Chronic Pain.
Median enrollment 126 across the 53 interventional studies, 209 across the 4 observational. Of the 40 that completed or were terminated, 37 (93%) have results posted.
This tab as a report to print or save as PDF → With an account.
VA Office of Research and Development is the lead sponsor of 1,774 studies on the registry; 394 are open to participants now.
Of its 213 completed or terminated interventional studies of FDA-regulated products, 185 (87%) have results posted.
6 of the studies in Chronic Pain by VA Office of Research and Development that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05925036VA Office of Research and DevelopmentNovel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis | 2026-12-31 |
| NCT05563792VA Office of Research and DevelopmentOptions for Pain Management Using Nonpharmacological Strategies | 2027-01-31 |
| NCT06058624VA Office of Research and DevelopmentAssessing the Efficacy of an Acceptance-Based Digital Intervention for Veterans With Chronic Pain | 2027-05-01 |
| NCT05811312VA Office of Research and DevelopmentBrain Connectivity Changes With Spinal Cord Stimulation and Treatment of Chronic Pain: A Resting State NIRS/EEG Study | 2027-06-30 |
| NCT06587607VA Office of Research and DevelopmentVR Mindfulness Training for Veterans With SCI | 2027-06-30 |
Add all 6 to your calendar (.ics) → With an account.
Among the 57 studies in Chronic Pain by VA Office of Research and Development, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The focus of this study is to determine whether adding Whole Health Coaching (WHC) improves pain care among adults with chronic pain and who are currently working with a pain management team (PMT) at the VA.
This multisite pragmatic effectiveness-implementation hybrid type 2 trial will randomize 432 patients to compare Pain Management Team - Usual Care (PMT-UC) vs. Pain Management Team Usual Care + Whole Health Coaching (PMT-WHC) on the primary composite outcome of pain-related interference and opioid safety. The investigators will also evaluate the impact of PMT-WHC on buprenorphine initiation and maintenance, evaluate implementation facilitation strategies for building and sustaining PMTs, and conduct a budget impact analysis.
The primary study goal is to evaluate the effectiveness of adding Whole Health Coaching to PMTs adhering to VA standards on the primary composite outcome of pain-related function and opioid safety, and secondary outcomes of wellbeing and physical functioning. Participants will have a 50/50 random chance of being assigned to (a) continuing to receive usual care from the PMT or (b) receiving WHC in addition to the usual care provided by the PMT.
Both groups will receive usual care from the PMT, which will include a baseline evaluation with at least two PMT clinicians. Follow-up appointments will vary based on clinical judgment of the PMT members, but most patients will be followed for at least six months with at least three follow-up appointments. Both groups will complete questionnaires via telephone at (1) baseline, (2) month 1, (3) month 3, (4) month 6, and (5) month 12. The questionnaires will ask about personal characteristics and demographics, pain, physical function, ability to do activities, social support, sleep, mental health, use of medications and health services, and substance use.
If assigned to participate in PMT-WHC, participants will work with a Whole Health Coach for a minimum of eight (8) individual sessions, with the option to continue coaching for up to 12 individual sessions. Whole Health Coaching begins by completing a Personalized Health Inventory (PHI), where progress is assessed within eight (8) dimensions of health and wellness: Physical, Emotional, Social, Spiritual, Intellectual, Environmental, Financial, and Occupational health. The Inventory culminates in defining personal values and overall goals for health and wellness (i.e., "What do you want your health for?") based on a person's mission, aspiration, and purpose. This will be used to create goals that become part of a Personal Health Plan. The Personal Health Plan emphasizes self-management strategies to manage pain. After the Plan is developed, ongoing support is provided from the Coach in coaching sessions. Coaches will meet with participants on a biweekly basis for the first three (3) months after randomization and on a monthly basis for the final two (2) months, for a minimum total of eight (8) sessions across approximately five (5) months. The sessions with the WHC will be recorded (audio recordings only, no photographs or video recordings). However, participation is still available in this study if participants decline to be recorded.
Participants may also be selected to participate in a qualitative interview. If selected, the interview covers participant experiences and opinions about working with the PMT, and, if relevant, the WHC. This interview will be recorded and will be approximately 60 minutes. Participants are not required to complete the interview and are still eligible to participate in this research study if the interview portion is declined.
The study will also evaluate implementation facilitation as a strategy to support PMTs in implementing care for patients with pain and opioid safety concerns. Implementation facilitation will include audit and feedback and other strategies tailored to each site. A budget impact analysis will monitor implementation and intervention costs.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exhibit evidence of at least ONE opioid safety concern (*indicators of opioid safety concerns described below).
Opioid safety concerns for inclusion purposes include:
Exclusion Criteria:
The PMT-WHC group will receive PMT Usual Care plus 8 sessions of Whole Health Coaching (WHC)
Other: Pain Management Team + Whole Health Coach (PMT-WHC) · Other: Pain Management Team-Usual Care (PMT-UC)
The PMT-UC group will receive PMT Usual Care
Other: Pain Management Team-Usual Care (PMT-UC)
Whole Health Coaching (WHC) begins by completing a Personalized Health Inventory (PHI), where progress is evaluated within 8 dimensions of health and wellness. The PHI culminates in defining personal values and overall goals for health and wellness (i.e., "What do you want your health for?"). This is used to create goals for a Personal Health Plan. The Plan emphasizes self-management strategies to manage pain. After the Plan is developed, ongoing support is provided from the Coach through 8-12 coaching sessions over approximately 5 months.
Also known as: PMT-WHC
Pain Management Team-Usual Care (PMT-UC) involves working with VA PMTs that includes working with PMTs comply with legislation requiring each medical center to have PMTs with expertise in pain, addiction, behavioral approaches, and rehabilitation approaches. PMTs will conduct multidisciplinary intakes (at least two provider types) with biopsychosocial assessments for all new patients. Follow-up care will be determined by the PMTs based on what is clinically indicated (with recommended minimum medication management follow ups at 1- 3- and 6-months for patients making medication changes).
Also known as: PMT-UC
Composite of Pain Interference and Opioid Safety
The primary outcome is a composite of pain-related interference and opioid safety. Success is met when pain-related interference and opioid safety improve. The pain component of the primary outcome is change in pain interference from baseline, measured on the Brief Pain Inventory, categorized as improved/not improved; where improvement: ≥1 point reduction in pain-related interference. The opioid safety component is defined as success in ≥1 of the following: (1) initiating and continuing buprenorphine for ≥ 90 days, (2) evidence of opioid taper ( \>25% reduction in daily full agonist opioid dose, including opioid discontinuation), (3) \>25% reduction in dose of benzodiazepine, gabapentin, pregabalin, nonbenzodiazepine hypnotic agents/sedative hypnotics, or skeletal muscle relaxant, (4) resolution of a positive baseline TAPS-2 score, (5) resolution of a positive AUDIT-C score, or (6) reduction in opioid-related difficulties as measured by the Prescribed Opioids Difficulties scale.
Time frame: 6 months
Opioid Safety
The investigators will evaluate improved opioid safety as a secondary outcome, whereby success (binary yes/no) is improvement in any of the following: 1. initiating and continuing buprenorphine for at least 90 days 2. evidence of an opioid taper (i.e., a \>25% reduction in daily full agonist opioid dose, including opioid discontinuation), measured at the 6-month follow-up visit 3. \>25% reduction in dose of benzodiazepine, gabapentin, pregabalin, nonbenzodiazepine hypnotic agents or sedative hypnotics, or skeletal muscle relaxant 4. resolution of a positive baseline TAPS-2 score, 5. resolution of a positive AUDIT-C score, or 6. reduction in opioid-related difficulties as measured by the Prescribed Opioids Difficulties (PODS) scale.
Time frame: 6 months, 12 months
Well-Being Signs (WBS) Tool
The Wellbeing Signs Tool is a three (3) item screening tool with items asking respondents to rate how well they are doing in their daily lives; higher scores indicated better wellbeing and life satisfaction.
Time frame: 6 months, 12 months
Pain Interference - Brief Pain Inventory (BPI)- Interference scale
The pain component of the composite primary outcome, measured at 6-month and 12-month follow-up, will be change in pain interference from baseline, measured on the Brief Pain Inventory - Interference scale, using 11-point scales ranging from 0 (no pan interference) to 10 (complete pain interference), with higher scores indicating a greater degree to which pain is disrupting quality of life, and categorized as improved/not improved with improvement defined as a ≥1 point reduction in pain-related interference.
Time frame: 6 months, 12 months
Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Functioning Short Form 6b
Physical Functioning: An assessment of the impact of pain on several aspects of functioning, including social and emotional processes as well as physical function (e.g., how much did pain interfere with your day to day activities).
Time frame: 6 months, 12 months
Composite of Pain Interference and Opioid Safety
We will examine the composite of pain-related interference and opioid safety (primary outcome at 6 mo) as a secondary outcome for durability of effects at 12 mo. The pain component of the primary outcome is change in pain interference from baseline, measured on the Brief Pain Inventory, categorized as improved/not improved; where improvement: ≥1 point reduction in pain-related interference. The opioid safety component is defined as success in ≥1 of the following: (1) initiating and continuing buprenorphine for ≥ 90 days, (2) evidence of opioid taper (\>25% reduction in daily full agonist opioid dose, including opioid discontinuation), (3) \>25% reduction in dose of benzodiazepine, gabapentin, pregabalin, nonbenzodiazepine hypnotic agents/sedative hypnotics, or skeletal muscle relaxant, (4) resolution of a positive baseline TAPS-2 score, (5) resolution of a positive AUDIT-C score, or (6) reduction in opioid-related difficulties as measured by the Prescribed Opioids Difficulties scale.
Time frame: 12 months
World Health Organization - Quality of Life (WHOQOL- 2)
The WHOQOL assesses individuals' perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns. The 2-item version of this measure (recommended by the NIH HEAL CDE Initiative) will be used.
Time frame: 6 months, 12 months
Patients' Global Impression of Change (PGIC)
Global Satisfaction with Treatment: A scale for respondents to rate the level of change experienced following treatment. The PGIC is a 7-point scale from 1 (very much better) to 7 (very much worse).
Time frame: 6 months, 12 months
Not enrolling at this site.
Plan to share: No
No publications or documents are linked to this record.
Started Nov 2025 (actual). Primary completion is estimated for Oct 2029, 46 months after the start.
Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's planned 46 months is above that.
Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
VA Office of Research and Development →